Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer. Wei W, Xiao X, Ren C, Zhang H, et al. Cell Death Discov 2026 May 28. doi: 10.1038/s41420-026-03182.

Read + Share

Amedeo Smart

Independent Medical Education

Wei W, Xiao X, Ren C, Zhang H, et al. Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer. Cell Death Discov 2026 May 28. doi: 10.1038/s41420-026-03182.
PMID: 42209463